Codify — Article

Protect Moms From Domestic Violence Act: study, grants, and HHS guidance

Authorizes a National Academy of Medicine study, a HRSA grant program, and HHS guidance to examine and address how violence and trauma contribute to maternal morbidity and mortality, with emphasis on underserved birthing people.

The Brief

The bill directs the Secretary of Health and Human Services to commission a comprehensive study of how intimate partner violence and related forms of trauma affect maternal morbidity and mortality, and creates a new grant program to develop and implement interventions for affected birthing people. It also requires HHS to issue clinical and partnership guidance to health systems and communities.

This is a targeted federal effort to close an evidence gap linking violence, trauma, and adverse pregnancy outcomes while seeding locally tailored interventions and improving how health systems screen, refer, and care for pregnant and postpartum survivors — especially in communities that face health disparities.

At a Glance

What It Does

Tasks the National Academy of Medicine (or an alternate entity if the Academy declines) to study links between violence/trauma and maternal outcomes; creates a HRSA-administered grant program for entities that serve survivors; and directs HHS to publish guidance for providers and systems. The grant program is funded through a three‑year authorization of appropriations.

Who It Affects

Federal health agencies that administer maternal and behavioral health programs, Tribal health entities and Tribal epidemiology centers, community-based violence and survivor services, federally qualified health centers, VA medical facilities, and hospitals and clinics that provide prenatal and postpartum care.

Why It Matters

The bill pairs new evidence-generation with capacity-building funds and operational guidance, aiming to align clinical practice, public health surveillance, and community-based supports to reduce pregnancy-related deaths and serious complications tied to violence and trauma.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The core research mandate asks an expert body to examine a broad set of exposures — from intimate partner violence and stalking to trafficking, reproductive coercion, intergenerational violence, trauma, and psychiatric disorders — and to map how those exposures change risk for suicide, homicide (including intimate partner homicide), overdose, substance use, and poor birth outcomes among pregnant and postpartum people. The study must also treat those exposures as potential social determinants of health and give special attention to how impacts differ across racial, ethnic, tribal, sexual orientation and gender identity groups, and adolescents.

Alongside the study, the bill creates a competitive grant program run by the Health Resources and Services Administration in partnership with other HHS components and the VA. Eligible applicants include government entities, community-based survivor services, Tribal organizations and Tribal epidemiology centers, FQHCs, behavioral health clinics certified as CCBHCs, hospitals, birth centers, universities, specialized substance-use programs for parents, and VA facilities.

Grantees are expected to pilot culturally relevant public and provider education, trauma‑informed clinical practices, improved maternal surveillance, and cross-sector partnerships that link clinical care to community supports. The statute establishes categories the Secretary should prioritize — for example, projects that address violence during pregnancy, work at Tribal epidemiology centers, or facilitate shared learning among recipients.The bill also compels HHS to produce and distribute operational guidance to states, Tribes, territories, providers, and managed care entities on universal education about healthy relationships, routine assessment of intimate partner violence and behavioral health conditions, trauma‑informed care planning, and building sustainable linkages between health providers and community-based organizations.

Finally, the legislation defines key terms — including maternal morbidity and maternal mortality (expressly including suicide, overdose, and homicide related to pregnancy) and a 12‑month postpartum period — so that research, grants, and guidance operate from a shared set of meanings.

The Five Things You Need to Know

1

The Secretary must first seek an arrangement with the National Academy of Medicine, but the statute permits selecting a different appropriate entity if the Academy declines.

2

The grant program explicitly allows Tribal epidemiology centers and Indian health organizations to apply and gives specific priority to Tribal-focused projects.

3

The bill’s definition of maternal mortality includes deaths from suicide, drug overdose, and homicide when those deaths are attributed to or aggravated by pregnancy-related conditions.

4

HRSA must coordinate grant awards with multiple HHS offices and the VA, signaling cross‑agency involvement in both grant selection and program design.

5

HHS is required to report to Congress on best practices from the grant program no later than three years after enactment and then every three years thereafter.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short title

▾

Names the measure the 'Protect Moms From Domestic Violence Act.' This is a housekeeping clause but frames the bill’s focus on maternal outcomes tied to violence and trauma.

Section 2

Study by National Academy of Medicine (or alternate entity)

▾

Directs HHS to arrange for an external, expert study on how a long list of violence- and trauma‑related exposures affect maternal morbidity and mortality. Practically, this will require access to multiple data streams (vital records, hospital discharge data, behavioral health records, and potentially criminal justice or social services records) and careful methods to attribute causation or aggravation. The provision’s explicit inclusion of diverse exposures and populations pushes the study to be intersectional in design and to produce stratified analyses for racial, tribal, and LGBTQIA2S+ groups.

Section 3

HRSA grants for innovative approaches

▾

Authorizes HRSA, in collaboration with other HHS components and the VA, to award grants to a broad set of eligible entities for interventions aimed at improving maternal and child health among survivors. The statute lists ten eligible entity types and sets out multiple prioritization criteria — for example, pregnancy-focused violence interventions, Tribal epidemiology center projects, surveillance improvements, cultural bias or antiracism training, and activities that convene grantees for shared learning. This section also includes an explicit authorization of appropriations for a multi‑year funding stream, which will shape program scale and award size during implementation.

2 more sections▾
Section 4

HHS guidance on screening, education, and partnerships

▾

Requires HHS to develop and disseminate guidance to states, Tribes, providers, and managed care entities on practical protocols such as universal education about healthy relationships, routine screening for intimate partner violence and behavioral health conditions, trauma‑informed care planning, and building sustainable community partnerships. From an operational standpoint, states and providers will likely use this guidance to revise prenatal and postpartum care protocols, update training curricula, and modify referral pathways to community‑based organizations that serve survivors.

Section 5

Definitions with analytic and programmatic effects

▾

Sets statutory definitions for terms that determine who counts for study and services: 'maternal morbidity' is defined to include mental health and substance use disorders aggravated by pregnancy; 'maternal mortality' covers deaths during pregnancy or within a year after that are attributed to pregnancy complications, explicitly including suicide, overdose, and homicide; and 'postpartum' is defined as 12 months. Those definitions will influence study inclusion criteria, grant eligibility, surveillance windows, and how outcomes are measured and reported.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Pregnant and postpartum survivors of intimate partner violence and related trauma: the study and grants aim to produce better-targeted services, culturally relevant education, and trauma-informed care that could reduce preventable morbidity and mortality.
  • Tribal health systems and Tribal epidemiology centers: enumerated as eligible applicants and priority recipients, improving access to funds and tailoring of interventions for Indigenous communities.
  • Community-based survivor organizations: eligible to receive grants to scale prevention and intervention work and to formalize partnerships with healthcare providers, strengthening referral pathways.

Who Bears the Cost

  • HHS and HRSA: responsible for administering the study, running the competitive grant program, coordinating across HHS offices and with the VA, and producing guidance — all requiring administrative capacity and any appropriation execution.
  • Health care providers and systems: expected to implement guidance, adopt routine assessment and trauma‑informed care practices, and build partnerships with community organizations, which will create training and workflow costs.
  • Grantee organizations: must design, implement, and evaluate pilot programs, handle reporting and convening responsibilities, and potentially absorb start-up or matching expenses not covered by grants.

Key Issues

The Core Tension

The bill confronts a central dilemma: generate detailed, population‑level data and expand screening to prevent pregnancy‑related deaths tied to violence, while avoiding data practices and clinical workflows that could endanger or re-traumatize survivors; balancing robust evidence and broader service reach against privacy, safety, and limited federal funding is the policy trade‑off at the heart of implementation.

The bill creates an ambitious research and service agenda but leaves several implementation details unresolved. The study will need access to sensitive clinical and social data to link violence exposures to outcomes; carving safe, privacy‑protecting pathways for data sharing will be technically and legally complex, especially across Tribal jurisdictions and state systems.

Similarly, the statutory priorities (Tribal centers, cultural bias training, improved surveillance) are broad; HHS will face tradeoffs in designing a grant competition—how to weigh investments in clinical training versus infrastructure for surveillance or community-driven prevention models.

Funding and timing also create tension. The authorization provides a finite pool of money across a limited period, which may constrain award sizes, evaluation budgets, and the sustainability of promising pilots.

Finally, heightened screening and surveillance can improve detection but risk unintended harms—mandatory reporting laws, exposure of survivors to surveillance by abusers, and stigma—unless HHS guidance is sufficiently specific about consent, confidentiality, and survivor-centered referral pathways.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.